DiagnoCure was incorporated in December 1994. In November 1996, the company issued common shares and warrants on the Montreal Stock Exchange in the course of it's initial public offering. The net proceeds amounted to $13.4 million (Can.). In December 1999, DiagnoCure's shares were listed on the Toronto Exchange.
R&D
To view this information, you must subscribe to PL Intelligence.
Partnerships
To view this information, you must subscribe to PL Intelligence.
Deals
To view this information, you must subscribe to PL Intelligence.
Senior management
To view this information, you must subscribe to PL Intelligence.
Board of directors
To view this information, you must subscribe to PL Intelligence.
Contact details
To view this information, you must subscribe to PL Intelligence.
All rights reserved. Terms and Conditions | Contact us
